Results 161 to 170 of about 119,037 (316)
Assessing primary hemostasis in cirrhosis: not only platelet count. [PDF]
Ferdinande K, Zanetto A.
europepmc +1 more source
RETRACTION: Oxidative Stress and Pulmonary Changes in Experimental Liver Cirrhosis. [PDF]
Cellular Longevity OMA.
europepmc +1 more source
Somatostatin Effect on Growth Factors in Hepatocellular Carcinoma. [PDF]
Tsakou A +5 more
europepmc +1 more source
Ascitic fluid concentrations of fibronectin and cholesterol [PDF]
Gerbes, Alexander L. +3 more
core
Liver Transplantation for Primary Biliary Cirrhosis [PDF]
Carcassonne, Christian +4 more
core +1 more source
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott +10 more
wiley +1 more source
A Retrospective Cohort Study on Hassab's Surgery as a Salvage Treatment for Patients with Secondary Prophylaxis Failure for Acute Variceal Bleeding. [PDF]
Zhang H +6 more
europepmc +1 more source
Spatial multi‐omics defines a DLL4–NOTCH3–driven capillary–mCAF axis orchestrating fibrotic remodeling and immune exclusion in hepatocellular carcinoma tumor cores, conferring immune checkpoint blockade resistance. Targeting stromal NOTCH3 disrupts this pro‐fibrotic niche, enhances T cell infiltration, and synergizes with anti‐PD‐1 therapy ...
Fansen Ji +18 more
wiley +1 more source
Role of Sigma-1 Receptors in the Paraventricular Nucleus and Myocardium during Cirrhotic Cardiomyopathy in Rats. [PDF]
Yu A, Li Y, Li J, Deng S.
europepmc +1 more source

